| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/12/2011 | US20110112067 Inhibitors of the Human Aldosterone Sythase CYP11B2 |
| 05/12/2011 | US20110112066 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 05/12/2011 | US20110112065 Modulators of dopamine neurotransmission |
| 05/12/2011 | US20110112064 Pyridyl Amide T-Type Calcium Channel Antagonists |
| 05/12/2011 | US20110112063 Pyrimidine derivatives as kinase inhibitors |
| 05/12/2011 | US20110112062 Carbamate And Urea Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 |
| 05/12/2011 | US20110112061 Pyridazinones, the preparation and the use thereof |
| 05/12/2011 | US20110112060 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 05/12/2011 | US20110112059 Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same |
| 05/12/2011 | US20110112058 Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 05/12/2011 | US20110112057 Sequential administration of 20,20,21,21,21-pentafluoro-17-hydroxy-11Beta-[4-(hydroxyacetyl)phenyl]-19-nor-17Alpha-pregna-4,9-dien-3-one and one or more progestogens for the treatment of gynaecological disorders |
| 05/12/2011 | US20110112056 Use of Carbon-2-Modified-Vitamin D Analogs to Induce the Formation of New Bone |
| 05/12/2011 | US20110112055 Compositions and methods for treating colitis |
| 05/12/2011 | US20110112054 Organophosphorous Compounds for the Activation of Gamma/Delta T Cells |
| 05/12/2011 | US20110112053 Pharmacological targeting of vascular malformations |
| 05/12/2011 | US20110112052 Spiro-oxindole mdm2 antagonists |
| 05/12/2011 | US20110112051 Dipeptidyl Peptidase-IV Inhibitors |
| 05/12/2011 | US20110112050 Separation of polysaccharides by charge density gradient |
| 05/12/2011 | US20110112049 Methods of preventing or treating diseases and conditions using complex carbohydrates |
| 05/12/2011 | US20110112048 Use of beta-glucan on upper respiratory tract infection symptoms and psychological well-being |
| 05/12/2011 | US20110112047 Methods for enhancing muscle performance and tone |
| 05/12/2011 | US20110112046 Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents |
| 05/12/2011 | US20110112045 Creamy o/w emulsion composition and production process thereof |
| 05/12/2011 | US20110112044 Novel uses of d-mannopyranose derivatives |
| 05/12/2011 | US20110112043 Method of utilizing physiological activity of rare saccharide and composition containing rare saccharide |
| 05/12/2011 | US20110112042 Novel flavonol compounds, a bioactive extract/fraction from ulmus wallichiana and its compounds for prevention for treatment of osteo-health related disorders |
| 05/12/2011 | US20110112041 Treatment of Male-Pattern Baldness by Local Induction of the Metabolic Defect of Fabry Disease |
| 05/12/2011 | US20110112036 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
| 05/12/2011 | US20110112032 Regulation of Brain Natriuretic Peptide and Catecholamines for the Treatment of Cardiovascular Diseases |
| 05/12/2011 | US20110112030 Methods of treating or preventing stent thrombosis |
| 05/12/2011 | US20110112022 Factor VIII Muteins with Reduced Immonugenicity |
| 05/12/2011 | US20110112019 Method for promoting hair growth or hair regeneration by maintaining or increasing expression of cell-adhesion factor |
| 05/12/2011 | US20110112014 Supplementation of propane-1,2,3-triol and water in fasting subjects |
| 05/12/2011 | US20110112011 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |
| 05/12/2011 | US20110112010 Octanoic acid formulations and methods of treatment using the same |
| 05/12/2011 | US20110111493 Compositions and Methods For Inhibiting Expression Of A Target Gene |
| 05/12/2011 | US20110111482 High Viscosity Xanthan Polymer Preparations |
| 05/12/2011 | US20110111398 Nucleic acid probe-based diagnostic assays targeting ssra genes of prokaryotic and eukaryotic organisms |
| 05/12/2011 | US20110111068 Inhibitors of cognitive decline |
| 05/12/2011 | US20110111066 Method and composition for improved anabolism |
| 05/12/2011 | US20110111062 Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| 05/12/2011 | US20110111061 Compositions and Methods for the Treatment of Skeletal Metastatic Lesions and Fractures |
| 05/12/2011 | US20110111059 Compositions Comprising Quinazoline Derivatives, Preparation Methods and Uses Thereof |
| 05/12/2011 | US20110111058 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha |
| 05/12/2011 | US20110111057 Methods and Compounds Useful to Induce Apoptosis in Cancer Cells |
| 05/12/2011 | US20110111055 Nutritional supplements for relief of dry eye |
| 05/12/2011 | US20110111049 Ischemia/reperfusion protection compositions and methods of using |
| 05/12/2011 | US20110111046 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors |
| 05/12/2011 | US20110111044 Nanoparticle compositions for nucleic acids delivery system |
| 05/12/2011 | US20110111041 Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells |
| 05/12/2011 | US20110111040 Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier |
| 05/12/2011 | US20110111039 Compositions and Methods for Inhibiting Gastric Acid Secretion |
| 05/12/2011 | US20110111038 Process for producing a stable concentrated dietary supplement and supplement produced thereby |
| 05/12/2011 | US20110111037 Orodispersible mannitol |
| 05/12/2011 | US20110111035 Inflammation-regulating compositions and methods |
| 05/12/2011 | US20110111031 Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof |
| 05/12/2011 | US20110111029 Composition for transdermal delivery of cationic active agents |
| 05/12/2011 | US20110111027 Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
| 05/12/2011 | US20110111026 Humidity-resistant drug formulations and methods of preparation thereof |
| 05/12/2011 | US20110111025 High Drug Load Formulations and Dosage Forms |
| 05/12/2011 | US20110111024 Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
| 05/12/2011 | US20110111022 Pharmaceutical formulation |
| 05/12/2011 | US20110111021 Pharmaceutical preparation |
| 05/12/2011 | US20110111018 Coated tablet formulations and uses thereof |
| 05/12/2011 | US20110111016 Non-dna base-containing polynucleotide compositions and their use for the modulation of immune responses |
| 05/12/2011 | US20110111014 Methods and compositions for treatment of neurological disorders |
| 05/12/2011 | US20110111013 Transdermal therapeutic system for administration of fentanyl or an analogue thereof |
| 05/12/2011 | US20110111012 Nanomaterial wound dressing assembly |
| 05/12/2011 | US20110111011 Sublingual apomorphine |
| 05/12/2011 | US20110111010 Method and Composition for Burned Skin |
| 05/12/2011 | US20110111009 Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients |
| 05/12/2011 | US20110111006 Conveniently implantable sustained release drug compositions |
| 05/12/2011 | US20110111002 Transport and delivery of glutathione into human cells using gold nanoparticles |
| 05/12/2011 | US20110110986 High-yield activation of polymer surfaces for covalent attachment of molecules |
| 05/12/2011 | US20110110984 Oral Dosage Form Comprising Tri-Substituted Glycerol Compounds |
| 05/12/2011 | US20110110972 Stimulation of an immune response by enantiomers of cationic lipids |
| 05/12/2011 | US20110110965 Compositions that induce t cell help |
| 05/12/2011 | US20110110961 Prolyl hydroxylase inhibitors |
| 05/12/2011 | US20110110960 Mannose-6-phosphate receptor mediated gene transfer into muscle cells |
| 05/12/2011 | US20110110958 Compositions and methods for the treatment of neoplasia |
| 05/12/2011 | US20110110957 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 05/12/2011 | US20110110952 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 05/12/2011 | US20110110951 Isolation of five novel genes coding for new fc receoptrs-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/12/2011 | US20110110948 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors |
| 05/12/2011 | US20110110947 Viral chemokine-antigen fusion proteins |
| 05/12/2011 | US20110110941 Wortmannin Analogs and Methods of Using Same in Combination with Chemotherapeutic Agents |
| 05/12/2011 | US20110110939 Methods and compositions for the treatment and diagnosis of systemic anthrax infection |
| 05/12/2011 | US20110110934 Treatment of uveitis |
| 05/12/2011 | US20110110933 Ectopic pregnancy treatment |
| 05/12/2011 | US20110110932 Combination treatment for ocular diseases |
| 05/12/2011 | US20110110930 Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill Subjects |
| 05/12/2011 | US20110110927 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 05/12/2011 | US20110110926 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| 05/12/2011 | US20110110925 Compositions and Methods for the Treatment and Diagnosis of Cancer |
| 05/12/2011 | US20110110923 Fish assay for eml4 and alk fusion in lung cancer |
| 05/12/2011 | US20110110921 Methods for Treating Bleeding Disorders |
| 05/12/2011 | US20110110918 Role of (de)acetylation in counteracting protein aggregation |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110916 Methods for treating and/or preventing cardiomyopathies by erk or jnk inhibition |
| 05/12/2011 | US20110110914 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |